Sample series to differentiate target nucleic acids from contaminant nucleic acids
Abstract:
This disclosure provides methods, compositions and kits for determining if nucleic acids detected in a sample such as a clinical sample are derived from contaminant pathogens or clinically-relevant pathogens.
Information query
Patent Agency Ranking
0/0